The development of stem cell-derived exosomes as a cell-free regenerative medicine

Journal of Circulating Biomarkers

Volumn 3, Issue , 2014, Pages

  Vishnubhatla, Indira ^a   Corteling, Randolph ^a   Stevanato, Lara ^a   Hicks, Caroline ^a   Sinden, John ^a  

^a RENEURON LTD   (United Kingdom)

Author keywords

Characterization; Exosomes; Isolation; Therapeutic potential

Indexed keywords

EID: 85017830044     PISSN: None     EISSN: 18494544     Source Type: Journal    
DOI: 10.5772/58597     Document Type: Review

References (115)

1. Matsa E, Sallam K and Wu JC (2014) Cardiac stem cell biology: glimpse of the past, present, and future. Circulation Research 114: 21-27.
2. Sinden JD, Vishnubhatla I and Muir KW (2012) Prospects for stem cell-derived therapy in stroke. Progress in Brain Research 201: 119-167.
3. Raval Z and Losordo DW (2013) Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circulation Research 112: 1288-1302.
4. Cieri N, Mastaglio S, Oliveira G, Casucci M, Bondanza A, et al. (2014) Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation. Immunological Reviews 257: 165-180.
5. Gnecchi M, Zhang Z, Ni A and Dzau VJ (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research 103: 1204-1219.
6. Hicks C, Stevanato L, Stroemer RP, Tang E, Richardson S, et al. (2013) In vivo and in vitro characterization of the angiogenic effect of CTX0E03 human neural stem cells. Cell Transplantation 22: 1541-1552.
7. Katare R, Stroemer P, Hicks C, Stevanato L, Patel S, et al. (2014) Clinical-grade human neural stem cells promote reparative neovascularization in mouse models of hindlimb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology 34: 408-418.
8. Bi B, Schmitt R, Israilova M, Nishio H and Cantley LG (2007) Stromal cells protect against acute tubular injury via an endocrine effect. Journal of the American Society of Nephrology: JASN 18: 2486-2496.
9. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, et al. (2007) Mesenchymal stem cellderived molecules reverse fulminant hepatic failure. PloS One 2: e941.
10. Yeo RWY, Lai RC, Tan KH and Lim SK (2013) Exosome: a novel and safer therapeutic refinement of mesenchymal stem cell. InTech Exosomes and Microvesicles 1: 1-12.
11. Camussi G, Deregibus MC and Cantaluppi V (2013) Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochemical Society transactions 41: 283-287.
12. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, et al. (2007) Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem cell research 1: 129-137.
13. Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, et al. (2011) Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem cell research 6: 206-214.
14. Lai RC, Chen TS and Lim SK (2011) Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regenerative medicine 6: 481-492.
15. Bang C and Thum T (2012) Exosomes: new players in cell-cell communication. The International Journal of Biochemistry and Cell Biology 44: 2060-2064.
16. Simons M and Raposo G (2009) Exosomes-vesicular carriers for intercellular communication. Current Opinion in Cell Biology 21: 575-581.
17. Thery C (2011) Exosomes: secreted vesicles and intercellular communications. F1000 Biology Reports 3: 15.
18. Chivet M, Javalet C, Hemming F, Pernet-Gallay K, Laulagnier K, et al. (2013) Exosomes as a novel way of interneuronal communication. Biochemical Society Transactions 41: 241-244.
19. Smalheiser NR (2007) Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biology Direct 2: 35.
20. Redis RS, Calin S, Yang Y, You MJ and Calin GA (2012) Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacology and Therapeutics 136: 169-174.
21. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, et al. (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305.
22. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, et al. (1996) B lymphocytes secrete antigen-presenting vesicles. The Journal of Experimental Medicine 183: 1161-1172.
23. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, et al. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL crosspriming. Nature Medicine 7: 297-303.
24. Clayton A (2012) Cancer cells use exosomes as tools to manipulate immunity and the microenvironment. Oncoimmunology 1: 78-80.
25. Camussi G, Deregibus MC and Tetta C (2010) Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Current Opinion in Nephrology and Hypertension 19: 7-12.
26. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, et al. (2006) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20: 847-856.
27. Eldh M, Ekstrom K, Valadi H, Sjostrand M, Olsson B, et al. (2010) Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PloS One 5: e15353.
28. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 9: 654-659.
29. Kim HS, Choi DY, Yun SJ, Choi SM, Kang JW, et al. (2012) Proteomic analysis of microvesicles derived from human mesenchymal stem cells. Journal of Proteome Research 11: 839-849.
30. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, et al. (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research 4: 214-222.
31. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, et al. (2013) Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism.
32. He J, Wang Y, Sun S, Yu M, Wang C, et al. (2012) Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology 17: 493-500.
33. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, et al. (2002) Production and characterization of clinical grade exosomes derived from dendritic cells. Journal of Immunological Methods 270: 211-226.
34. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, et al. (2011) Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circulation Research 109: 724-728.
35. Kang D, Oh S, Ahn SM, Lee BH and Moon MH (2008) Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. Journal of Proteome Research 7: 3475-3480.
36. Drago D, Cossetti C, Iraci N, Gaude E, Musco G, et al. (2013) The stem cell secretome and its role in brain repair. Biochimie 95: 2271-2285.
37. Thery C, Ostrowski M and Segura E (2009) Membrane vesicles as conveyors of immune responses. Nature Reviews Immunology 9: 581-593.
38. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, et al. (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cellular and Molecular Life Sciences: CMLS 68: 2667-2688.
39. Raposo G and Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. The Journal of Cell Biology 200: 373-383.
40. Hugel B, Martinez MC, Kunzelmann C and Freyssinet JM (2005) Membrane microparticles: two sides of the coin. Physiology 20: 22-27.
41. Harding C, Heuser J and Stahl P (1983) Receptormediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. The Journal of Cell Biology 97: 329-339.
42. Johnstone RM, Adam M, Hammond JR, Orr L and Turbide C (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). The Journal of Biological Chemistry 262: 9412-9420.
43. Pan BT, Teng K, Wu C, Adam M and Johnstone RM (1985) Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. The Journal of Cell Biology 101: 942-948.
44. Fevrier B and Raposo G (2004) Exosomes: endosomalderived vesicles shipping extracellular messages. Current Opinion in Cell Biology 16: 415-421.
45. Delcayre A and Le Pecq JB (2006) Exosomes as novel therapeutic nanodevices. Current Opinion in Molecular Therapeutics 8: 31-38.
46. Marcus ME and Leonard JN (2013) FedExosomes: engineering therapeutic biological nanoparticles that truly deliver. Pharmaceuticals 6: 659-680.
47. Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, et al. (2013) Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Advanced Drug Delivery Reviews 65: 336-341.
48. Kooijmans SA, Vader P, van Dommelen SM, van Solinge WW and Schiffelers RM (2012) Exosome mimetics: a novel class of drug delivery systems. International Journal of Nanomedicine 7: 1525-1541.
49. Camussi G, Deregibus MC, Bruno S, Cantaluppi V and Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney International 78: 838-848.
50. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, et al. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. Journal of Immunology 166: 7309-7318.
51. Chaput N and Thery C (2011) Exosomes: immune properties and potential clinical implementations. Seminars in Immunopathology 33: 419-440.
52. Peche H, Heslan M, Usal C, Amigorena S and Cuturi MC (2003) Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76: 1503-1510.
53. Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, et al. (2000) Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. Journal of Immunology 165: 1259-1265.
54. Wang K, Zhang S, Weber J, Baxter D and Galas DJ (2010) Export of microRNAs and microRNAprotective protein by mammalian cells. Nucleic Acids Research 38: 7248-7259.
55. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, et al. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. The Journal of Biological Chemistry 285: 17442-17452.
56. Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, et al. (2010) Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. The Journal of Cell Biology 189: 223-232.
57. Chen TS and Lim SK (2013) Measurement of precursor miRNA in exosomes from human ESCderived mesenchymal stem cells. Methods in Molecular Biology 1024: 69-86.
58. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, et al. (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PloS One 5: e11803.
59. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, et al. (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Research 38: 215-224.
60. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, et al. (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PloS One 4: e4722.
61. Rajendran L and Simons K (2005) Lipid rafts and membrane dynamics. Journal of Cell Science 118: 1099-1102.
62. Zomer A, Vendrig T, Hopmans ES, van Eijndhoven M, Middeldorp JM, et al. (2010) Exosomes: Fit to deliver small RNA. Communicative and Integrative Biology 3: 447-450.
63. Laude AJ and Prior IA (2004) Plasma membrane microdomains: organization, function and trafficking. Molecular Membrane Biology 21: 193-205.
64. Tan SS, Yin Y, Lee T, Lai RC, Yeo RW, et al. (2013) Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. Journal of Extracellular Vesicles 2.
65. Subra C, Laulagnier K, Perret B and Record M (2007) Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89: 205-212.
66. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, et al. (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319: 1244-1247.
67. Mathivanan S, Fahner CJ, Reid GE and Simpson RJ (2012) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Research 40: D1241-1244.
68. Lai RC, Arslan F, Tan SS, Tan B, Choo A, et al. (2010) Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. Journal of Molecular and Cellular Cardiology 48: 1215-1224.
69. Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, et al. (2012) Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome. International Journal of Proteomics 2012: 971907.
70. Koh W, Sheng CT, Tan B, Lee QY, Kuznetsov V, et al. (2010) Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. BMC Genomics 11 Suppl 1: S6.
71. Taylor DD, Zacharias W and Gercel-Taylor C (2011) Exosome isolation for proteomic analyses and RNA profiling. Methods in Molecular Biology 728: 235-246.
72. Simpson RJ, Jensen SS and Lim JW (2008) Proteomic profiling of exosomes: current perspectives. Proteomics 8: 4083-4099.
73. Li X, Arslan F, Ren Y, Adav SS, Poh KK, et al. (2012) Metabolic adaptation to a disruption in oxygen supply during myocardial ischemia and reperfusion is underpinned by temporal and quantitative changes in the cardiac proteome. Journal of Proteome Research 11: 2331-2346.
74. Guescini M, Genedani S, Stocchi V and Agnati LF (2010) Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. Journal of Neural Transmission 117: 1-4.
75. Lotvall J and Valadi H (2007) Cell to cell signalling via exosomes through esRNA. Cell Adhesion and Migration 1: 156-158.
76. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, et al. (2010) Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. Journal of Cellular and Molecular Medicine 14: 1605-1618.
77. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, et al. (2009) Mesenchymal stem cellderived microvesicles protect against acute tubular injury. Journal of the American Society of Nephrology:JASN 20: 1053-1067.
78. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, et al. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Research 68: 3566-3572.
79. Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, et al. (2012) Microvesicles derived from endothelial progenitor cells protect the kidney from ischemiareperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney International 82: 412-427.
80. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, et al. (2012) Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PloS One 7: e33115.
81. Redis RS, Berindan-Neagoe I, Pop VI and Calin GA (2012) Non-coding RNAs as theranostics in human cancers. Journal of Cellular Biochemistry 113: 1451-1459.
82. Chen X, Liang H, Zhang J, Zen K and Zhang CY (2012) Secreted microRNAs: a new form of intercellular communication. Trends in Cell Biology 22: 125-132.
83. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PloS One 3: e3694.
84. Gibbings DJ, Ciaudo C, Erhardt M and Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nature Cell Biology 11: 1143-1149.
85. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, et al. (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biology 12: 19-30; supp 11-13.
86. Ranghino A, Cantaluppi V, Grange C, Vitillo L, Fop F, et al. (2012) Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. International Journal of Immunopathology and Pharmacology 25: 75-85.
87. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, et al. (2011) Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrology, Dialysis, Transplantation 26: 1474-1483.
88. Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, et al. (2011) Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. Journal of Translational Medicine 9: 47.
89. Pollock K, Stroemer P, Patel S, Stevanato L, Hope A, et al. (2006) A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Experimental Neurology 199: 143-155.
90. Tetta C, Bruno S, Fonsato V, Deregibus MC and Camussi G (2011) The role of microvesicles in tissue repair. Organogenesis 7: 105-115.
91. Chan JKY and Lam PYP (2013) Human mesenchymal stem cells and their paracrine factors in the treatment of brain tumors. Cancer Gene Therapy: 1-5.
92. Beninson LA and Fleshner M (2014) Exosomes: An emerging factor in stress-induced immunomodulation. Seminars in Immunology.
93. Quesenberry PJ and Aliotta JM (2010) Cellular phenotype switching and microvesicles. Advanced Drug Delivery Reviews 62: 1141-1148.
94. Kim SH, Lechman ER, Bianco N, Menon R, Keravala A, et al. (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. Journal of Immunology 174: 6440-6448.
95. Schorey JS and Bhatnagar S (2008) Exosome function: from tumor immunology to pathogen biology. Traffic 9: 871-881.
96. Chen TS, Yeo RWY, Arslan F, Yin Y, Tan SS, et al. (2013) Efficiency of exosome production correlates inversely with the developmental maturity of MSC Donor. J Stem Cell Res Ther 3: 145.
97. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ and Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94: 3791-3799.
98. Thery C, Amigorena S, Raposo G and Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology/editorial board, Juan S Bonifacino [et al] Chapter 3: Unit 3 22.
99. Lai RC, Yeo RW, Tan KH and Lim SK (2013) Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regenerative Medicine 8: 197-209.
100. Vlassov AV, Magdaleno S, Setterquist R and Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochimica et Biophysica Acta 1820: 940-948.
101. Webber J and Clayton A (2013) How pure are your vesicles? Journal of Extracellular Vesicles 2.
102. Clayton A, Court J, Navabi H, Adams M, Mason MD, et al. (2001) Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. Journal of Immunological Methods 247: 163-174.
103. Witwer KW, Buzas EI, Bemis LT, Bora A, Lasser C, et al. (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. Journal of Extracellular Vesicles 2.
104. Xin H, Li Y, Buller B, Katakowski M, Zhang Y, et al. (2012) Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30: 1556-1564.
105. Kordelas L, Rebmann V, Ludwig A-K, Radtke S, Ruesing J, et al. (2014) MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versushost disease. Leukemia 4: 970-973.
106. Viaud S, Thery C, Ploix S, Tursz T, Lapierre V, et al. (2010) Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Research 70: 1281-1285.
107. Andrews DW, Resnicoff M, Flanders AE, Kenyon L, Curtis M, et al. (2001) Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulinlike growth factor type I receptor in malignant astrocytomas. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19: 2189-2200.
108. Morse MA, Garst J, Osada T, Khan S, Hobeika A, et al. (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. Journal of Translational Medicine 3: 9.
109. Dai S, Wei D, Wu Z, Zhou X, Wei X, et al. (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Molecular Therapy: The Journal of the American Society of Gene Therapy 16: 782-790.
110. Escudier B, Dorval T, Chaput N, Andre F, Caby MP, et al. (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derivedexosomes: results of the first phase I clinical trial. Journal of Translational Medicine 3: 10.
111. Xin H, Li Y, Liu Z, Wang X, Shang X, et al. (2013) Mir-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular Particles. Stem Cells.
112. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, et al. (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology 29: 341-345.
113. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, et al. (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nature Communications 2: 282.
114. Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, et al. (2013) Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Letters 335: 201-204.
115. Laine SK, Alm JJ, Virtanen SP, Aro HT and Laitala-Leinonen TK (2012) MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. Journal of Cellular Biochemistry 113: 2687-2695